Literature DB >> 11827829

Current achievements using ProteinChip Array technology.

Scot R Weinberger1, Enrique A Dalmasso, Eric T Fung.   

Abstract

Because of its inherent flexibility, the ProteinChip Array platform has demonstrated utility into basic research as well as clinical research. In the domain of basic research, it has been used to examine protein modifications, characterize protein-protein interactions and study signal transduction and enzymatic pathways. In clinical research, it has been used to elucidate and identify biomarkers of disease, and as a platform for predictive medicine.

Mesh：

Substances：

Year:  2002        PMID： 11827829     DOI： 10.1016/s1367-5931(01)00282-4

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN： 1367-5931            Impact factor:   8.822


  14 in total

1.  Differential exoprotease activities confer tumor-specific serum peptidome patterns.

Authors:  Josep Villanueva; David R Shaffer; John Philip; Carlos A Chaparro; Hediye Erdjument-Bromage; Adam B Olshen; Martin Fleisher; Hans Lilja; Edi Brogi; Jeff Boyd; Marta Sanchez-Carbayo; Eric C Holland; Carlos Cordon-Cardo; Howard I Scher; Paul Tempst
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

3.  Preliminary study on proteomics of gastric carcinoma and its clinical significance.

Authors:  Hong-Gang Qian; Jing Shen; Hong Ma; Hua-Chong Ma; Ya-Hui Su; Chun-Yi Hao; Bao-Cai Xing; Xin-Fu Huang; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

4.  Apolipoprotein AII levels are associated with the UP/UCr levels in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Takanori Yamagata; Takane Ito; Jun Odaka; Takashi Saito; Jun Aoyagi; Mariko Y Momoi
Journal:  Clin Exp Nephrol       Date:  2014-03-15       Impact factor: 2.801

5.  Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.

Authors:  Qi Liu; Xuerong Chen; Chaojun Hu; Renqing Zhang; Ji Yue; Guihui Wu; Xiaoping Li; Yunhong Wu; Fuqiang Wen
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

6.  Detection of cancer-specific markers amid massive mass spectral data.

Authors:  Wei Zhu; Xuena Wang; Yeming Ma; Manlong Rao; James Glimm; John S Kovach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure.

Authors:  Masahiro Wakao; Akihiro Saito; Koh Ohishi; Yuko Kishimoto; Tomoaki Nishimura; Michael Sobel; Yasuo Suda
Journal:  Bioorg Med Chem Lett       Date:  2008-01-19       Impact factor: 2.823

8.  Increased α1-antitrypsin levels in acute-phase Kawasaki disease as shown by SELDI-TOF MS analysis.

Authors:  Takahiro Kanai; Hirohiko Shiraishi; Ritei Uehara; Takane Ito; Mariko Y Momoi
Journal:  Pediatr Cardiol       Date:  2012-05-12       Impact factor: 1.655

9.  Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.

Authors:  Jingtao Wang; Xiao Wang; Fudong Yu; Jian Chen; Senlin Zhao; Dongyuan Zhang; Yang Yu; Xisheng Liu; Huamei Tang; Zhihai Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Investigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysis.

Authors:  Siv Meling; Olav M Kvalheim; Reidar Arneberg; Kjetil Bårdsen; Anne Hjelle; Martha J Ulvund
Journal:  BMC Res Notes       Date:  2013-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.